Addus HomeCare Co. (NASDAQ:ADUS) Holdings Decreased by Legato Capital Management LLC

Legato Capital Management LLC lowered its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 18.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,583 shares of the company’s stock after selling 1,934 shares during the quarter. Legato Capital Management LLC’s holdings in Addus HomeCare were worth $1,076,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new position in shares of Addus HomeCare in the third quarter valued at approximately $28,000. Farther Finance Advisors LLC lifted its position in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the period. KBC Group NV boosted its stake in Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares in the last quarter. Assetmark Inc. boosted its stake in Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of Addus HomeCare by 34.5% during the 4th quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock valued at $158,000 after purchasing an additional 323 shares during the period. Institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on ADUS. Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Oppenheimer raised their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Stephens boosted their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Addus HomeCare has a consensus rating of “Buy” and an average target price of $134.22.

Addus HomeCare Price Performance

Addus HomeCare stock opened at $114.26 on Thursday. Addus HomeCare Co. has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The firm’s 50 day simple moving average is $126.29 and its 200-day simple moving average is $127.19. The company has a market cap of $2.07 billion, a P/E ratio of 26.15, a price-to-earnings-growth ratio of 1.55 and a beta of 1.00.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.